Your browser doesn't support javascript.
loading
Subclonal evolution of CLL driver mutations is associated with relapse in ibrutinib- and acalabrutinib-treated patients.
Black, Gage S; Huang, Xiaomeng; Qiao, Yi; Tarapcsak, Szabolcs; Rogers, Kerry A; Misra, Shrilekha; Byrd, John C; Marth, Gabor T; Stephens, Deborah M; Woyach, Jennifer A.
Afiliação
  • Black GS; Department of Human Genetics, University of Utah, Salt Lake City, UT;
  • Huang X; Utah Center for Genetic Discovery, School of Medicine, University of Utah, Salt Lake City, UT.
  • Qiao Y; Department of Human Genetics, University of Utah, Salt Lake City, UT;
  • Tarapcsak S; Utah Center for Genetic Discovery, School of Medicine, University of Utah, Salt Lake City, UT.
  • Rogers KA; Department of Human Genetics, University of Utah, Salt Lake City, UT;
  • Misra S; Utah Center for Genetic Discovery, School of Medicine, University of Utah, Salt Lake City, UT.
  • Byrd JC; Department of Human Genetics, University of Utah, Salt Lake City, UT;
  • Marth GT; Utah Center for Genetic Discovery, School of Medicine, University of Utah, Salt Lake City, UT.
  • Stephens DM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.
  • Woyach JA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.
Blood ; 140(4): 401-405, 2022 07 28.
Article em En | MEDLINE | ID: mdl-35476648
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article